mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.009 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.46 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.01 |